Estrogen receptor microarrays: Subtype-selective ligand binding

被引:21
|
作者
Kim, SH [1 ]
Tamrazi, A [1 ]
Carlson, KE [1 ]
Daniels, JR [1 ]
Lee, IY [1 ]
Katzenellenbogen, JA [1 ]
机构
[1] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
关键词
D O I
10.1021/ja039586q
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We present the first example of a nuclear hormone receptor microarray, using for illustration the ligand-binding domains of the two estrogen receptors, ERα-LBD and ERβ-LBD. The proteins are printed and allowed to attach to aldehyde slides; the efficiency of attachment depends on whether the LBD is liganded with agonists (low attachment) versus liganded with antagonists or unliganded (high attachment). This suggests that attachment is orientation specific and involves principally a single lysine residue. The attached ERs retain good ligand-binding activity that can be assessed using an estradiol-fluorophore conjugate, and specific and ER subtype-selective binding of ligands can be determined conveniently in competitive binding assays. This powerful new, high-throughput technique to study ligand binding to ER-LBDs can be extended to other nuclear hormone receptors and adapted to assay the recruitment of coregulator proteins. Copyright © 2004 American Chemical Society.
引用
收藏
页码:4754 / 4755
页数:2
相关论文
共 50 条
  • [41] Parallel synthesis of a series of subtype-selective NMDA receptor antagonists
    Gregory, TF
    Wright, JL
    Wise, LD
    Meltzer, LT
    Serpa, KA
    Konkoy, CS
    Whittemore, ER
    Woodward, RM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (06) : 527 - 529
  • [42] Development of subtype-selective oestrogen receptor-based therapeutics
    Nilsson, Stefan
    Koehler, Konrad F.
    Gustafsson, Jan-Ake
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (10) : 778 - 792
  • [43] Subtype-selective GABAA receptor mimetics—novel antihyperalgesic agents?
    Hanns Ulrich Zeilhofer
    Robert Witschi
    Katharina Hösl
    Journal of Molecular Medicine, 2009, 87 : 465 - 469
  • [44] Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERα and ERβ) at AP-1 sites
    Weatherman, RV
    Scanlan, TS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 3827 - 3832
  • [45] Development of subtype-selective nicotinic receptor ligands as receptor antagonists at the dopamine-releasing receptor subtype.
    Crooks, PA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U911 - U911
  • [46] Characterization of flavonoids with potent and subtype-selective actions on estrogen receptors alpha and beta
    Bolt, Michael J.
    Oceguera, Jessica
    Singh, Pankaj K.
    Safari, Kazem
    Abbott, Derek H.
    Neugebauer, Kaley A.
    Mancini, Maureen G.
    Gorelick, Daniel A.
    Stossi, Fabio
    Mancini, Michael A.
    ISCIENCE, 2024, 27 (03)
  • [47] Examination of the role of TMH VII in subtype-selective ligand binding using semi-synthetic muscarinic receptors
    Fowler, CB
    LeVine, H
    Mosberg, HI
    PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 586 - 587
  • [48] Homology modeling of the estrogen receptor subtype β (ER-β) and calculation of ligand binding affinities
    DeLisle, RK
    Yu, SJ
    Nair, AC
    Welsh, WJ
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2001, 20 (02): : 155 - 167
  • [49] Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists
    Katz, Jonathan L.
    Hiranita, Takato
    Kopajtic, Theresa A.
    Rice, Kenner C.
    Mesangeau, Christophe
    Narayanan, Sanju
    Abdelazeem, Ahmed H.
    McCurdy, Christopher R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (01): : 109 - 124
  • [50] Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions
    Malin, David H.
    Henceroth, Mallori M.
    Izygon, Jonathan J.
    Nghiem, Duyen M.
    Moon, Will D.
    Anderson, Andrea P.
    Madison, Caitlin A.
    Goyarzu, Pilar
    Ma, Jian-Nong
    Burstein, Ethan S.
    NEUROSCIENCE LETTERS, 2015, 584 : 141 - 145